Authors/Disclosures
|
Cristina R. Wohlgehagen, MD
(Christus Trinity Clinic)
|
No disclosure on file |
|
Samuel Asanad
(UCLA David Geffen School of Medicine)
|
No disclosure on file |
|
Sidney Starkman, MD, FAAN
(UCLA Emergency Medicine Center)
|
No disclosure on file |
|
Scott Hamilton
|
No disclosure on file |
|
Robin A. Conwit, MD, FAAN
|
Dr. Conwit has nothing to disclose. |
|
Masayoshi Tada, MD, PhD
(Brain Research Institute, Niigata University)
|
No disclosure on file |
|
Nerses Sanossian, MD, FAAN
(Department of Neurology, USC)
|
Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma. |
|
Jeffrey L. Saver, MD, FAAN
(UCLA Health)
|
Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical. |